Portfolio mapping & regulatory signals
Structured signals—the feed your portfolio mapping trusts.
Signals consolidate regulatory change into scored, horizon-tagged records with origin and evidence. Portfolio assessment consumes that same feed so every product row ties back to defensible context—not a disconnected alert list.
- Portfolio risk concentration
- Per-product exposure & ownership
- Scored signals with origin context
Signals → portfolio
Same records, portfolio-grade outcomes
When you assess a SKU, you are not guessing whether Codex, Federal, or State threads apply: the signal record carries the join keys executives need for concentration and operators need for traceability.
Reference
Signal structure and use
What each signal carries
Title, summary, topic, origin, time horizon, a single Score for triage, confidence, recommended action language, evidence across related actions, and a derived Act / Prepare / Monitor posture.
Regulatory reviewers validate provenance and rationale;
Score & decision
One Score plus Act / Prepare / Monitor keeps triage honest: reviewers see why a signal is urgent or monitored instead of decoding competing impact, risk, and band labels.
Ready for portfolio rows
Origin and evidence snapshots are structured so assessment can explain why a product is exposed—supporting owner assignment, urgency, and audit questions without rebuilding a crosswalk.
Examples
Illustrative signal categories
Representative examples only; live data reflects your ingested sources and configured signal set. Categories help teams orient before opening line-level records.
| Metric category | Priority | Regulatory source | Jurisdiction tag | Impact context |
|---|---|---|---|---|
| Enforcement action | High | FDA | US - Federal | Immediate compliance trigger |
| Date marking data | Medium | SB 1234 (Proposed) | US - California | State-specific mandate |
| Ingredient bans | High | MAHA movement | US - Multi-State | Proposed legislative trend |
| Labeling changes | Medium | Codex | Global | Long-term directional trend |
Governance & access
Signals stay tied to evidence; ingredient research needs no roster; portfolio impact stays owned—built for operator review, not opaque alerts.
Start with individual usage-based access when you are ready. Enterprise teams use institutional onboarding with fit and governance review.
- Human-in-the-loop review stays in operator workflows.
- Recommendations remain evidence-linked and auditable.
- Portfolio mapping is role-aware with explicit ownership.